0001209191-22-035277.txt : 20220609
0001209191-22-035277.hdr.sgml : 20220609
20220609060017
ACCESSION NUMBER: 0001209191-22-035277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220607
FILED AS OF DATE: 20220609
DATE AS OF CHANGE: 20220609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WORLAND STEPHEN T
CENTRAL INDEX KEY: 0001283307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39866
FILM NUMBER: 221004848
MAIL ADDRESS:
STREET 1: 9050 CAMINO SANTA FE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc.
CENTRAL INDEX KEY: 0001828522
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853306396
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: (858) 925-8215
MAIL ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER COMPANY:
FORMER CONFORMED NAME: Locust Walk Acquisition Corp.
DATE OF NAME CHANGE: 20201015
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-07
0
0001828522
eFFECTOR Therapeutics, Inc.
EFTR
0001283307
WORLAND STEPHEN T
C/O EFFECTOR THERAPEUTICS, INC.
142 NORTH CEDROS AVENUE, SUITE B
SOLANA BEACH
CA
92075
1
1
0
0
President and Chief Executive
Common Stock
2022-06-07
4
P
0
20000
1.37
A
214978
D
Common Stock
562339
I
By Trust
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
2022-06-09